Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Treatment with Zavegepant Offers Improvements in Pain Severity Over 48-hours When Compared with Placebo—Post Hoc Results from a Randomized Placebo-controlled Trial (BHV3500-301)

              Author:Jayasinghe, Pramoda   O'Sullivan, Fiona   Popoff, Evan   Powell, Lauren   Cirillo, Jessica   Abraham, Lucy   Ailani, Jessica   

              Session Name:P9: Headache: Advances in CGRP Inhibition 3  

              Topic:Headache  

              Program Number:P9.007  

              Author Institution:Broadstreet Health Economics and Outcomes Research, Vancouver, BC, Canada  Pfizer R&D US Ltd, New York, NY  Pfizer R&D UK Ltd, Tadworth, United Kingdom  Medstar Georgetown Neurology, McLean, VA